Bard1 Life Sciences Limited (ASX:BD1)
Share Price and News


Company Profile:

The company is under health care sector and was founded in 1991. The headquarter of the company is situated in Roberts Road, Subiaco, Australia. BD1 is into commercializing and developing a blood test for lung cancer detection. BARD1 Ribonucleic Acid (RNA) Test and BARD1 Ovarian Cancer Test are also in its pipeline.



Code : ASX:BD1 Healthcare Company